These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 13254896)

  • 1. [Agranulocytosis during therapy of syphilis].
    TEMPSKI J; DZIECIOLOWSKI Z; SIKOROWA W
    Przegl Dermatol; 1955; 5(3):205-12. PubMed ID: 13254896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relative innoxiousness of bismuth-arsenic treatments during the last years of use of said treatment].
    CARRERA JL
    Rev Medica Hosp Esp; 1955; 25(7-9):57-65. PubMed ID: 13298231
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results obtained in the treatment of recent syphilis employing so-called long combined methods. II. Arsenosan-bismuth].
    CARRERA JL
    Sem Med; 1955 Jun; 106(25):913-8. PubMed ID: 13246711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term results of intensive treatment of recent syphilis with penicillin combined with arsenoxide and bismuth, administered simultaneously].
    CARRERA JL
    Sem Med; 1955 Aug; 107(6):311-5. PubMed ID: 13255977
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of therapy of latent and asymptomatic syphilis in a prison population. I. Clinical outcome with reference to cardiovascular and central nervous system syphilis and related to a nonsyphilitic control population.
    KAPLAN BI; RYAN J; THOMAS E; CUTLER JC; JENKINS KH
    J Chronic Dis; 1958 Apr; 7(4):300-11. PubMed ID: 13539142
    [No Abstract]   [Full Text] [Related]  

  • 6. [HOW TO EVALUATE A POSITIVE SEROLOGICAL REACTION AFTER THE COMPLETION OF ANTISYPHILITIC TREATMENT?].
    MILICH MV
    Vestn Dermatol Venerol; 1964 Jan; 38():44-8. PubMed ID: 14177918
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactions to twenty-day intensive therapy with mapharsen and bismuth for syphilis with a note on the use of BAL in their management.
    CORMIA FE; BLAUNER SG
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):135-49. PubMed ID: 20289293
    [No Abstract]   [Full Text] [Related]  

  • 8. [The correlations between penicillin, arsenobenzols and bismuth in vitro and in vivo].
    POPCHRISTOV P; LEWKOV A; TOSCHKOV A; ANGELOV N; GEORGIEV G; KAPNILOV S
    Dermatol Wochenschr; 1955; 132(47):1225-35. PubMed ID: 13285156
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the treatment of early syphilis by maximal arsenic-bismuth therapy; inquiry conducted in the official antivenereal services of Spain].
    GAY PRIETO J; CORDERO SOROA A
    Actas Dermosifiliogr; 1953 Jan; 44(4):244-54. PubMed ID: 13050531
    [No Abstract]   [Full Text] [Related]  

  • 10. [Remote results of arseno-bismuth therapy of syphilis; data of a survey].
    GAY PRIETO ; CORDERO SOROA A
    Actas Dermosifiliogr; 1953 Feb; 44(5):363-72. PubMed ID: 13050549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Complications after injection of bismuth preparation].
    JARMILA N
    Prakt Lek; 1955 Aug; 35(15-16):374. PubMed ID: 13266700
    [No Abstract]   [Full Text] [Related]  

  • 12. On the frequency of the Jarisch-Herxheimer reaction.
    BLOM-IDES CS; POLANO MK; HERRMANN WA
    Acta Derm Venereol; 1955; 35(2):118-21. PubMed ID: 13248416
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of early syphilis by the twenty-six-week mapharsen-bismuth schedule.
    STERNBERG TH; LEIFER W
    Am J Syph Gonorrhea Vener Dis; 1947 Mar; 31(2):124-34. PubMed ID: 20289292
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toward a standardization of treatment of recently acquired syphilis. I. Treatment of recently acquired syphilis with arsenolan-bismuth].
    CARRERA JL
    Rev Medica Hosp Esp; 1950; 20(1-4):23-40. PubMed ID: 15424502
    [No Abstract]   [Full Text] [Related]  

  • 15. The intensive treatment of early syphilis: in 9 to 15 weeks with triweekly injections of mapharsen (oxophenarsine hydrochloride) and concomitant weekly injections of bismuth: an analysis of the results in 110 cases.
    DEXTER DD
    Am J Syph Gonorrhea Vener Dis; 1947 Sep; 31(5):533-41. PubMed ID: 20262385
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical results and by effects in early syphilis with combined arsenical-bismuth treatment.
    MØLLER P
    Acta Derm Venereol Suppl (Stockh); 1950 Sep 4-10; 31(Suppl. 24):30-41. PubMed ID: 14829187
    [No Abstract]   [Full Text] [Related]  

  • 17. [Accelerated ars no-bismuth treatment of primary secondary syphilis].
    DUJARDIN J
    Maroc Med; 1949 Nov; 28(294):730. PubMed ID: 15400679
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term results of intensive chemotherapeutic treatments in recent syphilis].
    CARRERA JL
    Sem Med; 1955 Jun; 106(26):970-3. PubMed ID: 13246720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Results of the examination of 1340 primary-secondary syphilitics who followed regular arsenobismuth and bismuth treatment for a minimum of 4 years].
    DEGOS R; VISSIAN L; BASSET H
    Bull Soc Fr Dermatol Syphiligr; 1950; 57(2):209-11. PubMed ID: 15434640
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of syphilis with penicillin and bismuth but without arsenic].
    ROZENTUL MA; ASTVATSATUROV KR; ZAKHAROVA LI; BASOVA OD; TROFIMOVA EM
    Vestn Venerol Dermatol; 1952; 14(5):31-3. PubMed ID: 13005970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.